sign in sign up
<<
Home , Keystone virus, Rickettsiosis

Appendix B: Kentucky Timeline for Disease Reporting

147 KENTUCKY TIMELINE FOR DISEASE REPORTING

Blank Page

148 902 KAR 2:020: Amended Table of Reportable Diseases and Conditions in Kentucky (Effective November 16, 2016) http://www.lrc.ky.gov/kar/902/002/020.htm

Notification of the following Notification of the following diseases shall be considered Notification of the following diseases or conditions shall be diseases shall be considered urgent and shall be made considered priority and shall be made within one (1) business day: routine and shall be made within twenty-four (24) hours: within five (5) business days:

Anthrax; Arboviral diseases, neuroinvasive and Hantavirus , non-Hantavirus Babesiosis; Botulism; non-neuroinvasive, including: pulmonary syndrome Coccidioidomycosis; (multiple cases, temporally or (a) California serogroup diseases, Hantavirus pulmonary syndrome Creutzfeldt-Jakob disease; spatially clustered); including diseases caused by: (HPS);Hemolytic uremic syndrome /; Diphtheria; 1. California virus; (HUS), Hepatitis C, acute; Hepatitis A, acute; 2. Jamestown Canyon virus; post-diarrheal; Hepatitis C infection in a pregnant Measles; 3. Keystone virus; Hepatitis B, acute; woman; Meningococcal ; 4. La Crosse virus; Hepatitis B infection in a pregnant Hepatitis C infection in an infant or a Novel influenza A virus infections; 5. Snowshoe hare virus; and woman; child aged five (5) years or less; 6. Trivittatus ; Hepatitis B infection in an infant or a ; Newborns born to Hepatitis C positive (b) virus disease; child aged five (5) years or less; Poliomyelitis; mothers at the time of delivery; (c) Eastern equine encephalitis Newborns born to Hepatitis B positive , animal; Histoplasmosis; virus disease; mothers at the time of delivery; Rabies, human; (d) disease; Influenza-associated mortality Lead poisoning; Rubella; (e) St. Louis encephalitis virus disease; ; Legionellosis; Severe Acute Respiratory Syndrome- (f) Venezuelan equine encephalitis Listeriosis; Lyme Disease; associated Coronavirus (SARS-CoV) disease; Mumps; Malaria; disease; (g) disease; Norovirus outbreak; Rickettsiosis Smallpox; (h) Western equine encephalitis Pertussis; (Rocky Mountain Spotted Fever); ; virus disease; and Pesticide-related illness, acute; Toxoplasmosis; and Varicella; (i) disease or infection or Psittacosis; Trichinellosis (Trichinosis); Viral hemorrhagic fevers due to: the birth of a child to a mother ; (a) Crimean-Congo Hemorrhagic who was Zika-positive or Rabies post exposure prophylaxis; HIV infection or AIDS diagnosis; Fever virus; Zika-inconclusive during any stage Rubella, congenital syndrome; (b) Ebola virus; of pregnancy or during the ; (c) Lassa virus; periconceptional period; Shiga toxin-producing E. coli (STEC); ; (d) Lujo virus; Brucellosis (cases not temporally or ; Chlamydia trachomatis infection; (e) ; or spatially clustered); Streptococcal toxic-shock syndrome; ; (f) New world including: ; Streptococcus pneumoniae, invasive ; 1. Guanarito virus; Carbon monoxide poisoning disease; Lymphogranuloma venereum; or 2. Junin virus; ; Tetanus; Syphilis, other than primary, secondary, Cryptosporidiosis; Toxic-shock syndrome (other than 3. Machupo virus; early latent, or congenital. infections; Streptococcal); 4. Sabia virus. O157:H7; Tuberculosis; ; Foodborne disease outbreak; ; influenzae invasive disease; Vibriosis; Hansen's disease (leprosy); Waterborne disease outbreak;

Syphilis - primary, secondary, or Congenital syphilis; early latent; 149 902 KAR 2:020: Amended Table of Reportable Diseases and Conditions in Kentucky (Effective November 16, 2016) http://www.lrc.ky.gov/kar/902/002/020.htm

Submission of Clinical Isolates, or if Routine Notification within Not Available, the Direct Specimen Report Immediately By Five (5) Business Days, by Electronic Laboratory for the Following Diseases Telephone Reporting, Beginning October 1, 2016 (Section 3)

Botulism; Cyclosporiasis; (1) A suspected incidence of bioterrorism Brucellosis; Giardiasis; caused by a biological agent; Campylobacteriosis; Hepatitis B laboratory test results whether reported as positive or negative; (2) Submission of a specimen to the Cholera and diseases caused by other 1. Include the serum bilirubin levels taken within ten (10) days of the Kentucky Division of Laboratory Vibrio species; test of a patient who has tested positive; or Services for select agent identification Diphtheria; 2. Include the serum alanine aminotransferase levels taken within or select agent confirmation testing; or Escherichia coli O157:H7; ten (10) days of the test of a patient who tested positive; Hemolytic Uremic Syndrome (HUS) – Hepatitis C laboratory test results whether reported as positive or negative; (3) An outbreak of a disease or condition Post Diarrheal; 1. Include the serum bilirubin levels taken within ten (10) days of the that resulted in multiple Listeriosis; test of a patient who has tested positive; or hospitalizations or death. Measles; 2. Include the serum alanine aminotransferase levels taken within Meningococcal infections; ten (10) days of the test of a patient who tested positive; and (4) An unexpected pattern of cases, Rabies animal; Varicella laboratory test results reported as positive for: suspected cases, or deaths which may Rubella; 1. Isolation of varicella virus from a clinical specimen; indicate the following shall be reported Salmonellosis; 2. Varicella antigen detected by direct fluorescent test; immediately by telephone to the local Shiga toxin-producing E. coli (STEC); 3. Varicella-specific nucleic acid detected by polymerase chain reaction health department in the county where Shigellosis; (PCR); or the health professional is practicing or Tuberculosis; 4. A significant rise in serum anti-varicella immunoglobulin G (IgG) where the facility is located: Tularemia; and antibody level by a standard serologic assay. (a) A newly-recognized infectious Typhoid fever. agent; (Reports made pursuant to this section [of 902 KAR 2:020] shall include a diagnosis) (b) An outbreak; (c) An emerging pathogen which may ------pose a danger to the health of the public; Multi-drug Resistant Organisms: 1. Vancomycin-intermediate Staphylococcus aureus (VISA); (d) An epidemic; or 2. Vancomycin-resistant Staphylococcus aureus (VRSA); (e) A non-infectious chemical, 3. Methicillin-resistant Staphylococcus aureus (MRSA); or biological, or radiological agent. 4. Vancomycin-resistant Enterococcus species (VRE). 5. Clostridium difficile (C. difficile) 6. Carbapenem-resistant (CRE) 7. Cephalosporin-resistant Klebsiella 8. Extended–spectrum beta-lactamase Gram negative organisms (ESBL) 9. Multidrug-resistant – Acinetobacter 10. Multidrug-resistant Pseudomonas

150